Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies - Slideshow
Relay Therapeutics, Inc. has released initial clinical data regarding Zovegalisib, a treatment for vascular anomalies. The information was shared through a slide deck published in conjunction with the event. This development is part of the company's ongoing efforts to advance its therapeutic offerings.
- ▪Relay Therapeutics, Inc. discussed initial clinical data for Zovegalisib.
- ▪The data pertains to the treatment of vascular anomalies.
- ▪A slide deck was published to accompany the presentation of this information.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4907197-relay-therapeutics-inc-rlay-discusses-initial-clinical-data-for-zovegalisib-in-vascular"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
